相似文献
1
Corrigendum: Infection of a β-galactosidase-deficient mouse strain with Theiler's murine encephalomyelitis virus reveals limited immunological dysregulations in this lysosomal storage disease.
Front Immunol. 2025 Apr 25;16:1610299. doi: 10.3389/fimmu.2025.1610299. eCollection 2025.
2
Infection of a β-galactosidase-deficient mouse strain with Theiler's murine encephalomyelitis virus reveals limited immunological dysregulations in this lysosomal storage disease.
Front Immunol. 2025 Apr 9;16:1467207. doi: 10.3389/fimmu.2025.1467207. eCollection 2025.
3
Theiler's virus infection chronically alters seizure susceptibility.
Epilepsia. 2010 Aug;51(8):1418-28. doi: 10.1111/j.1528-1167.2009.02405.x. Epub 2009 Dec 1.
4
Theiler's virus infection in nude mice: viral RNA in vascular endothelial cells.
J Virol. 1988 Oct;62(10):3589-96. doi: 10.1128/JVI.62.10.3589-3596.1988.
5
Theiler's virus is eliminated by a gamma-interferon-independent mechanism in the brain.
J Neuroimmunol. 1994 Jun;52(1):79-86. doi: 10.1016/0165-5728(94)90165-1.
6
IFNAR signaling of neuroectodermal cells is essential for the survival of C57BL/6 mice infected with Theiler's murine encephalomyelitis virus.
J Neuroinflammation. 2023 Mar 5;20(1):58. doi: 10.1186/s12974-023-02737-6.
7
Differential transcription of matrix-metalloproteinase genes in primary mouse astrocytes and microglia infected with Theiler's murine encephalomyelitis virus.
J Neurovirol. 2008 May;14(3):205-17. doi: 10.1080/13550280802008305.
8
Theiler's murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: Models for multiple sclerosis and epilepsy.
J Neuroimmunol. 2017 Jul 15;308:30-42. doi: 10.1016/j.jneuroim.2017.02.012. Epub 2017 Feb 12.
9
Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion.
Mol Genet Metab. 2016 Feb;117(2):199-209. doi: 10.1016/j.ymgme.2015.12.002. Epub 2015 Dec 8.
10
Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody.
J Virol. 1989 May;63(5):2081-7. doi: 10.1128/JVI.63.5.2081-2087.1989.
Zotero 插件